Dr. Zhang received his B.S. from Lanzhou University, China and his M.S. from the Institute of Modern Physics, Chinese Academy of Sciences. He joined Purdue University in 1996, and worked in Dr. Fred E. Regnier’s laboratory. After receiving his Ph.D. degree in 2001, Dr. Zhang joined Beyond Genomics, Inc., a systems biology company in Boston, to develop bioanalytical and bioinformatics platforms for disease biomarker discovery and validation. In 2004, Dr. Zhang returned to Purdue University as the Director of
Dr. Weng is Scientific Director, Janssen Fellow, and Head of East Coast Bioanalytical Chemistry and Pharmacokinetics, Janssen Research & Development, Johnson and Johnson, Spring House, PA, USA. In addition to support various programs at Janssen, current research interests of his group include novel bioanalytical quantitation for biomarkers, protein/peptides, and novel drug conjugates and unique formulations. Dr. Weng has over 100 peer-reviewed journal publications,
Dr. Yi He studied applied chemistry and environmental chemical engineering at Shanghai Jiao Tong University in China and analytical chemistry in National University of Singapore (NUS) before completing her Ph.D. in analytical chemistry in 2004 at the City University of New York (CUNY). She took a position as an Assistant Professorof Chemistry at John Jay College of Criminal Justice of CUNY in fall 2004 and was promoted to full professor in 2016.
Mingming Ma is the Principal Research Scientist in Crop Protection Regulatory Sciences, Corteva Agriscience. She has more than 15 years experiences in analytical and bioanalytical chemistry for both small and large molecules. She has 26 peer-reviewed journal publications and co-edited a book. Dr. Ma serves as an American Chemical Society - AGRO division executive committee since 2019.
Agilent Technologies (from 1997 to current)
Column R&D, HPLC column expert
· Developed HPLC column packing materials such as 1.8 µm totally porous particles,
College: Yale University, 1973
M.S.: U. of Nebraska Medical Center (Biochemistry, 1977).
Ph.D.: Purdue U. (Biochemistry, 1980). Advisor: Fred Regnier. Thesis work: Development of HPLC packing materials and techniques for protein applications.
Tao received her Ph.D. in Analytical Chemistry from University of Florida in 2013. Her doctoral study under professor Weihong Tan explored the applications of aptamer-conjugated nanomaterials in cancer diagnostics and therapy. She then joined Small Molecule Pharmaceutical Sciences in Genentech, Inc. in 2014, where she has contributed to various projects ranging from antibody-drug conjugates to peptides and traditional small molecule drugs, with research interests in developing novel analytical and chromatographic techniques for characterization of new drug modalities.
Zhengwei (Tony) Chen
Tony received his Ph.D. in Analytical Chemistry from University of Wisconsin-Madison in 2018. His doctoral study under professor Lingjun Li developing LC-MS methods for glycoproteomics study in Alzheimer's disease. He then joined Analytical Chemistry group in Regeneron Pharmceuticals, Inc. in 2018, where he has contributed to developing mass spectrometry-based analytical characterization activities to support from early stage to late stage drug development activities with multi-functional project teams, including research, formulation and process development etc.
Michael W. Dong, PhD. Born in Shanghai and raised in Hong Kong, Michael is a principal consultant at MWD Consulting (www.mwd-consulting.com). He was formerly senior scientist at Genentech, Small Molecule Analytical Chemistry and QC, research director at Synomics Pharma (CRO), research fellow at Purdue Pharma, and senior staff scientist at Applied Biosystems / Perkin-Elmer. He holds a PhD in Analytical Chemistry from City University of New York and a certificate in Biotechnology
Dr. Tao Jiang is an expert in HPLC, GC and LC/MS with more than 20 years of research experience in separation media, instrumentation and their applications in pharmaceutical field. Currently she is a technical fellow in R&D at Mallinckrodt Pharmaceuticals. Dr. Jiang has published 23 papers, two book chapters, and 34 patents/patent applications; she has delivered more than 50 conference presentations. She received her M.S. in Organic
UCLA: Postdoctoral 1991-1992.
Harvard University: Ph.D., 1991.
Lanzhou University: B.Sc. in Chemistry, 1984.
Dr. Chuping Luo is the Senior Research Scientist in Advanced Materials Technology. His interests includes developing new chromatographic stationary phases and application methods for bio-separation and small molecules.
From 2010 to 2015, Dr. Luo was the Principal Scientist in Waters Corporation, where he developed many critical methods in solving the applications in Supercritical Fluid Chromatography
Dr. Fengjian Shi is a scientist in Analytical Development at Biogen. Prior to joining Biogen, Fengjian received his B.S. in Chemistry from Nanjing University in 2011 and PhD in Analytical Chemistry from Temple University in 2017.
Dr. Perry G. Wang is a chemist in the Office of Regulatory Science, US Food and Drug Administration (US FDA). His interests include analytical method development and validation for drugs and constituents of foods and cosmetic products using advanced instrumentation. His expertise focuses on high throughput drug analysis by LC/MS/MS. His current research focuses on developing analytical methods for constituents in cosmetics and dietary supplements by GC/MS/MS and LC/MS/MS.
Dr. Baomin Xin, Senior VP of DMPK & Bioanalytical Services department at Pharmalegacy, obtained his PhD under Professor Milton L Lee at Brigham Young University (BYU). During his PhD research, he was one of the chief designers who design and built an orthogonal extraction time-of-flight mass spectrometer. He designed, and made the mechanical drawings of, the inlet assembly, including the main flange, RF-only quadrupole focusing lens set, inter-quad lens, DC/RF quads set, and exit slit. Outstanding
Dr. Frank J. Yang earned his Ph.D. in Physical Chemistry from the University of Utah under the supervising of Professor Calvin J. Giddings in 1973. In 1976, Dr. Yang joined Varian Associates Walnut Creek Division, California where he became Manager for the Chromatography Research Group. During his 10 years association with Varian, he had involved and was responsible for the development of 3000 series gas chromatograph, 5500 Series liquid chromatograph, and capillary column GC
Yan-Bo Yang, Ph.D., President&CEO, BioPharmaDev, Inc.
Dr. Yan-Bo Yang has 30 years strong experiences in chemical analyses and purification of both small pharmaceutical compounds and large biologics; generic drug product developments; cGMP, regulations and compliances; and project management. Dr. Yang is an expert in chromatography theory, chromatography column technology and
MDr. Michael Ye is the R&D Manager of Liquid Separation Department in Supelco, a division of Sigma-Aldrich. He has over 20 years experience in chromatographic analysis and separation including over 10 years experience in separation product research and development. He received his bachelor's degree from the Department of Chemistry, Lanzhou University and Ph.D. from the Institute of Chemistry, Chinese Academy of Science, Beijing, China. He has a MBA degree from Colorado State University.
Edward Yeung received his A.B. in chemistry from Cornell University and his Ph.D. in Chemistry from the University of California at Berkeley. Since then, he has been on the chemistry faculty at Iowa State University, where he is currently Robert Allen Wright Professor and Distinguished Professor in Liberal Arts and Sciences. His research interests span both spectroscopy and chromatography. He was an Associate Editor of Analytical
Prof. Yukui Zhang
Dr. Emmi Zheng received her B.S. in chemistry from Jilin University, and Ph.D. in analytical chemistry from Dr. David Hage’s research group at the University of Nebraska-Lincoln (UNL). Emmi is currently an R&D Scientist in the biotherapeutics product development group at Smith & Nephew. Emmi has ten year research experience in bioanalytical chemistry.